Management of Takayasu arteritis: a systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis
Open Access
Abstract
Objective: To collect available evidence on management of large vessel vasculitis to inform the 2018 update of the EULAR management recommendations. Methods: Two independent systematic literature reviews were performed, one on diagnosis and monitoring and the other on drugs and surgical treatments. Using a predefined PICO (population, intervention, comparator and outcome) strategy, Medline, Embase and Cochrane databases were accessed. Eligible papers were reviewed and results condensed into a summary of findings table. This paper reports the main results for Takayasu arteritis (TAK). Results: A total of 287 articles were selected. Relevant heterogeneity precluded meta-analysis. Males appear to have more complications than females. The presence of major complications, older age, a progressive disease course and a weaker inflammatory response are associated with a more unfavourable prognosis. Evidence for details on the best disease monitoring scheme was not found. High-quality evidence to guide the treatment of TAK was not found. Glucocorticoids are widely accepted as first-line treatment. Conventional immunosuppressive drugs and tumour necrosis factor inhibitors were beneficial in case series and uncontrolled studies. Tocilizumab failed the primary endpoint (time to relapse) in a randomised controlled clinical trial; however, results still favoured tocilizumab over placebo. Vascular procedures may be required, and outcome is better when performed during inactive disease. Conclusions: Evidence to guide monitoring and treatment of patients with TAK is predominantly derived from observational studies with low level of evidence. Therefore, higher-quality studies are needed in the future.Keywords
Funding Information
- European League Against Rheumatism
This publication has 127 references indexed in Scilit:
- Anaortic Off-pump Coronary Artery Bypass Grafting in Patients with Takayasu's ArteritisThe Korean Journal of Thoracic and Cardiovascular Surgery, 2013
- Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long‐term followupArthritis Care & Research, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- Risk factors for cardiovascular disease and endothelin-1 levels in Takayasu arteritis patientsClinical Rheumatology, 2008
- Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-upAnnals of the Rheumatic Diseases, 2008
- Quality of life of patients with Takayasu’s arteritisJournal of Vascular Surgery, 2008
- Mycophenolate mofetil reduces disease activity and steroid dosage in Takayasu arteritisClinical Rheumatology, 2007
- Infliximab in Takayasu arteritis: a safe alternative?Clinical Rheumatology, 2006
- Surgical Treatment of Aortic Regurgitation due to Takayasu ArteritisCirculation, 2005
- Balloon angioplasty of the aorta in Takayasu's arteritis: Initial and long-term resultsAmerican Heart Journal, 1992